Induced Antileukemic Activity after Blast Modulation is Independent from Immune Checkpoint Marker Expression on Patients’ Blasts or T Cells. acbr [Internet]. 2025 Dec. 18 [cited 2026 Sep. 17];9(6):521-4. Available from: https://fortunejournals.org/ojs/index.php/acbr/article/view/15154